Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA BIOCON CIPLA/
BIOCON
 
P/E (TTM) x 34.0 36.7 92.8% View Chart
P/BV x 4.3 4.1 104.8% View Chart
Dividend Yield % 0.4 0.2 253.7%  

Financials

 CIPLA   BIOCON
EQUITY SHARE DATA
    CIPLA
Mar-22
BIOCON
Mar-22
CIPLA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,083424 255.4%   
Low Rs806315 256.0%   
Sales per share (Unadj.) Rs269.768.2 395.7%  
Earnings per share (Unadj.) Rs31.78.2 389.2%  
Cash flow per share (Unadj.) Rs44.814.9 299.8%  
Dividends per share (Unadj.) Rs5.000.50 1,000.0%  
Avg Dividend yield %0.50.1 391.1%  
Book value per share (Unadj.) Rs257.868.5 376.1%  
Shares outstanding (eoy) m806.811,200.60 67.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.55.4 64.6%   
Avg P/E ratio x29.845.3 65.7%  
P/CF ratio (eoy) x21.124.7 85.3%  
Price / Book Value ratio x3.75.4 68.0%  
Dividend payout %15.86.1 256.9%   
Avg Mkt Cap Rs m762,177443,622 171.8%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29918,801 187.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,63381,840 265.9%  
Other income Rs m3,2176,891 46.7%   
Total revenues Rs m220,85188,731 248.9%   
Gross profit Rs m43,29813,827 313.1%  
Depreciation Rs m10,5208,142 129.2%   
Interest Rs m1,064676 157.3%   
Profit before tax Rs m34,93311,900 293.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3382,115 441.5%   
Profit after tax Rs m25,5959,785 261.6%  
Gross profit margin %19.916.9 117.8%  
Effective tax rate %26.717.8 150.4%   
Net profit margin %11.812.0 98.4%  
BALANCE SHEET DATA
Current assets Rs m147,10883,823 175.5%   
Current liabilities Rs m49,12938,280 128.3%   
Net working cap to sales %45.055.6 80.9%  
Current ratio x3.02.2 136.7%  
Inventory Days Days63101 62.5%  
Debtors Days Days692 6.3%  
Net fixed assets Rs m119,415117,184 101.9%   
Share capital Rs m1,6146,003 26.9%   
"Free" reserves Rs m206,36476,281 270.5%   
Net worth Rs m207,97782,284 252.8%   
Long term debt Rs m4,16239,985 10.4%   
Total assets Rs m266,523201,007 132.6%  
Interest coverage x33.818.6 181.9%   
Debt to equity ratio x00.5 4.1%  
Sales to assets ratio x0.80.4 200.6%   
Return on assets %10.05.2 192.2%  
Return on equity %12.311.9 103.5%  
Return on capital %17.010.3 165.0%  
Exports to sales %26.20-   
Imports to sales %8.27.8 105.3%   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,8036,360 279.9%   
Fx inflow Rs m60,1808,885 677.3%   
Fx outflow Rs m17,8036,360 279.9%   
Net fx Rs m42,3762,525 1,678.3%   
CASH FLOW
From Operations Rs m33,25911,766 282.7%  
From Investments Rs m-18,719-16,991 110.2%  
From Financial Activity Rs m-15,9982,421 -660.8%  
Net Cashflow Rs m-1,323-2,433 54.4%  

Share Holding

Indian Promoters % 13.5 39.7 34.0%  
Foreign collaborators % 20.1 21.0 95.9%  
Indian inst/Mut Fund % 49.4 23.6 209.6%  
FIIs % 27.7 15.8 175.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 39.4 168.7%  
Shareholders   388,864 369,816 105.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Cipla vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Biocon Share Price Performance

Period Cipla Biocon S&P BSE HEALTHCARE
1-Day -0.98% -1.05% -0.40%
1-Month -3.95% 5.12% -2.28%
1-Year 20.84% -23.08% -5.90%
3-Year CAGR 33.85% -0.40% 20.84%
5-Year CAGR 13.34% -11.27% 11.41%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Biocon paid Rs 0.5, and its dividend payout ratio stood at 6.1%.

You may visit here to review the dividend history of Cipla, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Adani Green Raises US$ 200 M| Zydus Lifesciences Gets USFDA Nod| Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets and ended the day with a new record closing high. This was due to a sharp rally witnessed in IT and media indices.